Innovative Use of the Noom Monitor Mobile Application for CBT-GSH in Binge Eaters

描述(由申请人提供)：神经性暴食症和暴饮暴食障碍以严重的损害和精神共病为标志，影响到大约5%-7%的美国人口。有指导的自助认知行为疗法(CBT-GSH)已被证明是减少这两种疾病患者暴饮暴食的有效治疗方法。然而，客户和治疗师的理解都是有限的。一个重要的因素是自我监控，这是认知行为疗法的核心组成部分，对于客户来说，传统的书面形式既耗时又繁琐，而且对于治疗师来说，很难在有限的时间内全面解决这一问题。这笔赠款建议利用新兴的移动应用程序技术，作为提高引导自助的效力、可访问性和有效性的工具。这将通过将WorkSmart Lab目前用于健康饮食和锻炼的商业移动产品Noom Monitor调整为一个自我监控应用程序，该应用程序集成了用于暴食者的CBT-GSH工具。此外，该应用程序还将用于向治疗师提供有关其患者进展的实时反馈。通过预先设置的警报，治疗师将被实时通知客户饮食模式的任何剧烈变化，该警报旨在为治疗师分配一个等级，代表每个客户的健康状况。改编的Noom Monitor应用程序的可行性和有效性将通过一项随机对照试验来检验，该试验比较了CBT-GSH+APP和CBT-GSH，该试验是在西奈山医学院的饮食和体重障碍项目中进行的。在这项提议之外，创新地利用技术来协助心理健康干预具有广泛的影响，这将被用来为这一产品的进一步开发和商业化制定战略。

DESCRIPTION (provided by applicant): Bulimia nervosa and binge eating disorder are marked by significant levels of impairment and psychiatric comorbidity, affecting approximately 5-7% of the US population. Guided self-help cognitive behavioral (CBT-GSH) therapy has been show to be an effective treatment to reduce binge eating for patient with both disorders. However, there is limited uptake among both clients and therapists. One significant factor is self-monitoring, the central component of cognitive- behavioral therapy, which is both time-intensive and cumbersome in its traditional paper format for clients, as well as difficult to comprehensively address in a time-limited session for the therapist. This grant proposes to utilize emerging mobile application technology, as a tool for increasing the potency, accessibility, and efficacy of guided self-help. This will be accomplished by adapting WorkSmart Lab's current commercial mobile product for healthy eating and exercise, Noom Monitor, into a self-monitoring application integrating CBT-GSH tools for binge eaters. Additionally, the application will be used to facilitate real-time feedback to therapists about their patient progres. Therapists will be notified in real-time about any drastic changes in client eating patterns through pre-set alerts designed to assign a grade to therapists, representing each client's well-being. The feasibility and efficacy of the adapted Noom Monitor application will be examined through a randomized control trial comparing CBT-GSH + APP with CBT-GSH conducted at the Mount Sinai School of Medicine's Eating and Weight Disorders Program. The innovative utilization of technology to assist in mental health interventions has widespread implications outside of this proposal, which will be used to strategize the further development and commercialization of this product.